Hypophosphataemic osteomalacia due to urinary kappa light chain.
Pope
R M
RM
Department of Endocrinology, Leeds General Infirmary, UK.
Belchetz
P E
PE
D001539:Bendroflumethiazide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017674:Hypophosphatemia / Q000150:complications* / Q000188:drug therapy; D007145:Immunoglobulin kappa-Chains / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000652:urine; D010710:Phosphates / Q000627:therapeutic use
D007145:Immunoglobulin kappa-Chains; D010710:Phosphates; D001539:Bendroflumethiazide